Skip to main content
Home
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Chile
  • China
  • Colombia
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Netherlands
  • South Africa
  • Spain
  • Switzerland
  • Taiwan
  • United Kingdom
  • USA
  • Contact
  • English
  • French
GBT €8.76
  • Our Group
    • Guerbet in a nutshell
    • Our Corporate Responsibilities
    • Corporate Governance
    • Intrasense and Guerbet
      • Intrasense, a Guerbet Group subsidiary: Innovating in AI together
    • Careers
  • Products & Solutions
    MRI
    • Home of MRI Innovations
    • Artirem®
    • Dotarem®
    • Elucirem™ (Gadopiclenol)
    • Injectors, Accessories & Consumables
    • MRI Accessories
    • Consumables for Diagnostic Imaging
    • OptiStar® Elite
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    CT
    • Home of MRI Innovations
    • Conray® / Cysto-Conray®
    • Micropaque® / Microtrast®
    • Optiray®
    • Telebrix® Gastro
    • Xenetix® / ScanBag® by Xenetix®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • OptiBolus®
    • OptiOne™
    • OptiVantage™ Multi-use
    • OptiVantage™ Single-use
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    Cath Lab
    • Home of MRI Innovations
    • Optiray®
    • Xenetix® / ScanBag® by Xenetix®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • Illumena® Néo
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    Interventional Radiology
    • Pharmaceutical Drugs
    • Lipiodol® Ultra Fluid
    • Medical Devices
    • Qitexio®
    Solutions d’imagerie interventionnelle

    Interventional Imaging Solutions

    Explore our Solutions
    Women's Health
    • Pharmaceutical Drugs
    • Patent Blue V
    • Lipiodol® Ultra Fluid
    Fertility and women's health

    Women’s Health

    Explore our Solutions
  • Investors
    • Key Figures
    • Stock Performance
    • Financial Policy
    • Presentations, Reports & Regulated information
    • Agenda
    • General Meetings
  • Media
  • Educational Resources
  • Patient Resources
    • Blue November
    • Liver Cancer Awareness Month
    • Osteoarthritis
    • Vascular embolization
  • 100 years
    • Celebrating 100 years
    • Guerbet Saga

Media

Welcome to Guerbet Media section for journalists. The press releases are intended for their professional use. Find our latest press releases and our media resources.

Media…
  1. Homepage
  2. Media

Our Latest Press Releases

Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT

Read the article

Changes to the Composition of Guerbet’s Board of Directors

Read the article

Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)

Read the article
Lipiodol® Ultra Fluid indicated for hysterosalpingography (HSG) in women undergoing infertility workup in Ireland

UK approves Lipiodol® Ultra Fluid for hysterosalpingography in women undergoing infertility workup

Read the article
Guerbet commits to patients affected by infertility  during the European Fertility Week

Guerbet commits to patients affected by infertility during the European Fertility Week

Read the article
David Hale appointed CEO of Guerbet as from January 1, 2020 to accelerate deployment of the Group’s strategy

Guerbet appoints a second director representing employees to its board

Read the article
David Hale appointed CEO of Guerbet as from January 1, 2020 to accelerate deployment of the Group’s strategy

Guerbet strengthens its Executive Committee to step up its transformation

Read the article
2019 annual results

2020 half-year results

Read the article
We are committed to enhance patients quality of life worldwide…

Lipiodol® Ultra Fluid indicated for hysterosalpingography (HSG) for tubal flushing in women undergoing infertility workup in Denmark

Read the article
Revenue at June 30, 2020

Revenue at June 30, 2020

Read the article
Guerbet Optimizes its Industrial Network

Guerbet Optimizes its Industrial Network

Read the article
Lipiodol® Ultra Fluid indicated for hysterosalpingography (HSG) in women undergoing infertility workup in Ireland

Hungary and the Netherlands approve Lipiodol® Ultra Fluid for hysterosalpingography in women undergoing infertility workup

Read the article
  • ‹
  • 5
  • 6
  • 7
  • 8
  • 9
  • Current page10
  • 11
  • 12
  • 13
  • ›
Image
Logo Guerbet
  • Legal Information
  • Cookie Policy
  • Data Protection Policy
  • Patents
  • Contact
Copyright © Guerbet
2026
  • LinkedIn
  • Twitter
  • Instagram
  • YouTube